Skip to main content

Table 6 HLA-DP single amino acid polymorphisms**

From: Lack of HLA predominance and HLA shared epitopes in biliary Atresia

Positions

Amino acid

Patients (111) n (%)

Controls (91) n (%)

Odds Ratio

Pu value*

Pc value*

8

V

59(53.15)

39(42.86)

1.2

0.15

NS

9

H

8(7.21)

11(12.09)

0.6

0.33

NS

9

Y

53(47.75)

31(34.07)

1.4

0.05

NS

11

L

43(38.74)

35(38.46)

1.0

0.97

NS

35

Y

27(24.32)

10(10.99)

2.2

0.01

NS

36

A

85(76.58)

67(73.63)

1.0

0.63

NS

36

V

78(70.27)

66(72.53)

1.0

0.72

NS

55

A

86(77.48)

68(74.73)

1.0

0.65

NS

55

D

75(67.57)

64(70.33)

1.0

0.67

NS

56

A

88(79.28)

71(78.02)

1.0

0.83

NS

56

E

75(67.57)

64(70.33)

1.0

0.67

NS

57

D

36(32.43)

27(29.67)

1.1

0.67

NS

65

L

41(36.94)

26(28.57)

1.3

0.21

NS

69

E

44(39.64)

34(37.36)

1.1

0.74

NS

76

V

45(40.54)

32(35.16)

1.2

0.43

NS

84

D

60(54.05)

40(43.96)

1.2

0.15

NS

84

G

97(87.39)

80(87.91)

1.0

0.91

NS

85

E

60(54.05)

40(43.96)

1.2

0.15

NS

85

G

99(89.19)

80(87.91)

1.0

0.78

NS

86

A

60(54.05)

40(43.96)

1.2

0.15

NS

86

P

99(89.19)

80(87.91)

1.0

0.78

NS

87

M

99(89.19)

80(87.91)

1.0

0.78

NS

87

V

60(54.05)

40(43.96)

1.2

0.15

NS

  1. *Pu, uncorrected P values; Pc, corrected P values.
  2. † Polymorphic amino acid positions 8, 9, 11, 33, 35, 36, 55, 56, 57, 65, 69, 76, 84, 85, 86, 87 ** Not displaying amino acid residues that were present in 90% or greater in both patient and control groups, or were present in 10% or fewer in both patient and control groups.